Canada: Study Says Increasing HIV Drug Treatment Will Save Millions Through Prevention
July 12, 2010
Expanding HIV therapy in British Columbia from 50 percent to 75 percent of those eligible would curtail the spread of the epidemic and save US $900 million over 30 years, suggests recent mathematical modeling from Canadian researchers.
The center has been expanding the use of HAART, which is available at no cost to all B.C. residents. The center's initiative is the basis of a pilot project to identify and provide care to HIV-positive residents in the Downtown Eastside area of Vancouver and in Prince George, B.C. The targets are sex workers, injection drug users, and men who have sex with men.
"Increasing the HAART treatment rate from 50 [percent] to 75 percent of clinically eligible individuals in British Columbia appears to be a cost-effective strategy based on this model," the authors concluded. "These cost-effectiveness results are consistent with public health objectives: all individuals who are eligible for an established lifesaving treatment should receive it."
The full report, "Expanding Access to HAART: A Cost-Effective Approach for Treating and Preventing HIV," was published online ahead of print in AIDS (doi: 10.1097/QAD.0b013e32833af85d).
07.07.2010; Camille Bains
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)